IP Library Granted Patent US 11,633,597
Granted Patent B2
US 11,633,597 · App. 16/798,370 · Granted Apr 25, 2023

Contingent cardio-protection for epilepsy patients

Inventor: Ivan Osorio (Leawood, KS)
Assignee: Flint Hills Scientific, LLC.
A61N1/36064A61N1/36053A61N1/36114A61N1/36139A61N1/36185A61N1/0556A61N1/36117
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,633,597
App. No.
16/798,370
Granted
Apr 25, 2023
Kind
B2
Abstract

Disclosed are methods and systems for treating epilepsy by stimulating a main trunk of a vagus nerve, or a left vagus nerve, when the patient has had no seizure or a seizure that is not characterized by cardiac changes such as an increase in heart rate, and stimulating a cardiac branch of a vagus nerve, or a right vagus nerve, when the patient has had a seizure characterized by cardiac changes such as a heart rate increase.

Claims (25)

1. A method of treating a patient having epilepsy comprising:

receiving at least one body data stream;

analyzing the at least one body data stream using a seizure detection algorithm to detect a first condition where an epileptic seizure event has occurred and a second condition where the epileptic seizure event is not present;

receiving a cardiac signal of the patient;

analyzing the cardiac signal to determine the patient's heart rate;

based on a first determination that the first condition is present, determining whether the epileptic seizure event is characterized by a decrease in the patient's heart rate from a reference value or a normative value;

applying a first electrical signal to a vagus nerve of the patient based on the first determination that the first condition is present and that the epileptic seizure event is characterized by the decrease in the patient's heart rate from the reference value or the normative value; and

applying a second electrical signal to the vagus nerve of the patient based on a second determination that the second condition is present.

2. The method of claim 1 , wherein the first electrical signal is a pulsed electrical signal that blocks action potential conduction in the vagus nerve.

3. The method of claim 1 , wherein the second electrical signal is not a vagus nerve conduction blocking electrical signal.

4. The method of claim 1 , wherein the first electrical signal is a pulsed electrical signal that blocks action potential conduction in the vagus nerve and the second electrical signal is not a vagus nerve conduction blocking electrical signal.

5. The method of claim 1 , wherein determining the first condition comprises:

determining a first heart rate of the patient prior to detecting of an onset of the epileptic seizure event;

determining a second heart rate of the patient in response to detecting the onset of the epileptic seizure event using the seizure detection algorithm;

comparing the first heart rate and the second heart rate; and

determining that the epileptic seizure event is characterized by the decrease in the patient's heart rate based on the second heart rate is less than the first heart rate.

6. The method of claim 5 , wherein determining the first heart rate comprises determining a heart rate during a non-seizure period.

7. The method of claim 1 , wherein applying the first electrical signal comprises applying a high frequency pulsed electrical signal to a target site of the vagus nerve, such that at least a fraction of axons in the vagus nerve are incapable of supporting action potential propagation across the target site.

8. The method of claim 1 , wherein applying the second electrical signal comprises applying an electrical signal according to a programmed duty cycle having at least a programmed on-time and a programmed off-time.

9. The method of claim 8 , further comprising interrupting the applying of the second electrical signal based on a determination that the patient has had the epileptic seizure event characterized by the decrease in the patient's heart rate.

10. The method of claim 1 further comprising:

sensing the patient's heart rate in response to providing the first electrical signal, and modifying the first electrical signal to maintain the patient's heart rate between an upper heart range threshold and a lower heart rate range threshold.

11. The method of claim 1 , wherein at least one of the first electrical signal and the second electrical signal is a microburst electrical signal characterized by having a number of pulses per microburst from 2 pulses to about 25 pulses, an interpulse interval of about 2 msec to about 50 msec, an interburst period of at least 100 msec, and a microburst duration of less than about 1 second.

12. The method of claim 1 , wherein the second electrical signal is selected from 1) an electrical signal that generates action potentials in at least a population of nerve fibers of the vagus nerve, and 2) a subthreshold electrical signal that does not generate action potentials in a population of the fibers of the vagus nerve.

13. The method of claim 1 , further comprising issuing a warning that the patient has had the epileptic seizure event characterized by the decrease in the patient's heart rate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2022
From: OSORIO, IVAN
To: FLINT HILLS SCIENTIFIC, LLC
Reel/Frame 059988/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2020
From: OSORIO, IVAN
To: FLINT HILLS SCIENTIFIC, LLC
Reel/Frame 051895/0661 →
Continuity (6)
Continuation 15437155 · Feb 20, 2017
Division 14050173 · Oct 9, 2013
Continuation In Part 13601099 · Aug 31, 2012
Continuation In Part 12020097 · Jan 25, 2008
Continuation In Part 12020195 · Jan 25, 2008
Related Publication 20200206508A1 · Jul 2, 2020